Welcome to Photospectra Health Sciences

Photospectra is the first company in Canada and the USA to undertake a clinical trial of Photobiomodulation (PBM) for Dry AMD.
We have completed enrolment of all patients for our clinical trial.
We expect PBM to be a major new treatment for dry AMD patients – safe, effective and affordable when proven in clinical studies.
We are dedicated to proving the merits of PBM through ethical, responsible, well designed and well-executed clinical studies.